HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon Pimstone Selected Research

XEN1101

11/2023Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
11/2019TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon Pimstone Research Topics

Disease

1Seizures (Absence Seizure)
11/2023
1Partial Epilepsies (Epilepsy, Partial)
11/2023
1Iron Overload
01/2023
1Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
01/2022
1Epilepsy (Aura)
11/2019
1Type 2 Diabetes Mellitus (MODY)
12/2004
1Atherosclerosis
12/2004

Drug/Important Bio-Agent (IBA)

2Potassium Channels (Potassium Channel)IBA
11/2023 - 11/2019
2XEN1101IBA
11/2023 - 11/2019
2Triglycerides (Triacylglycerol)IBA
01/2022 - 12/2004
1KCNQ3 Potassium ChannelIBA
11/2023
1MetalsIBA
01/2023
1Apolipoprotein B-100 (Apo B 100)IBA
01/2022
1LipidsIBA
01/2022
1Lipoproteins (Lipoprotein)IBA
12/2004
1Fenofibrate (CiL)FDA LinkGeneric
12/2004
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2004

Therapy/Procedure

1Therapeutics
11/2023